Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010

In this paper, Ferrari and colleagues analyzed the burden of depressive disorders in GBD 2010 and identified depressive disorders as a leading cause of burden. The authors present severity proportions; burden by country, region, age, sex, and year; as well as burden of depressive disorders as a risk factor for suicide and ischemic heart disease. Please see later in the article for the Editors' Summary

[1]  T. Vos,et al.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[2]  A. Ferrari,et al.  The epidemiological modelling of dysthymia: application for the Global Burden of Disease Study 2010. , 2013, Journal of affective disorders.

[3]  Abraham D. Flaxman,et al.  The Epidemiological Modelling of Major Depressive Disorder: Application for the Global Burden of Disease Study 2010 , 2013, PloS one.

[4]  Janet B W Williams.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[5]  K. Naidoo,et al.  Erratum: GBD 2010 Country Collaboration. GBD 2010 country results: A global public good (The Lancet (2013) 381 (965-970)) , 2013 .

[6]  E. Jessop.  Health in the UK: could do even better? , 2013, The Lancet.

[7]  Alan D. Lopez,et al.  GBD 2010 country results: a global public good , 2013, The Lancet.

[8]  Ronan A Lyons,et al.  UK health performance: findings of the Global Burden of Disease Study 2010 , 2013, BDJ.

[9]  D. Gunnell,et al.  Changing trends in the prevalence of common mental disorders in Taiwan: a 20-year repeated cross-sectional survey , 2013, The Lancet.

[10]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[11]  Mohsen Naghavi,et al.  GBD 2010: design, definitions, and metrics , 2012, The Lancet.

[12]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[13]  Alan D. Lopez,et al.  Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[14]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[15]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[16]  W. Cullen,et al.  Research confuses me: what is the difference between case-control and cohort studies in quantitative research? , 2013, Irish medical journal.

[17]  T. Vos,et al.  Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature , 2012, Psychological Medicine.

[18]  H. Whiteford,et al.  Predicting the Impact of the 2011 Conflict in Libya on Population Mental Health: PTSD and Depression Prevalence and Mental Health Service Requirements , 2012, PloS one.

[19]  H. Whiteford,et al.  Mental disorders as risk factors: assessing the evidence for the Global Burden of Disease Study , 2011, BMC medicine.

[20]  H. Whiteford,et al.  Factors Influencing Risk of Premature Mortality in Community Cases of Depression: A Meta-Analytic Review , 2011 .

[21]  H. Whiteford,et al.  Should Global Burden of Disease Estimates Include Depression as a Risk Factor for Coronary Heart Disease? , 2011, BMC medicine.

[22]  Richard J. K. Taylor,et al.  Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: a systematic review. , 2011, Social science & medicine.

[23]  Sreeram V Ramagopalan,et al.  Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study , 2011, BMC medicine.

[24]  L. Knifton,et al.  Mental health and wellbeing of adults , 2011 .

[25]  D. Segal.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) , 2010 .

[26]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[27]  E. Susser,et al.  Two plus two equals three? Do we need to rethink lifetime prevalence? , 2009, Psychological Medicine.

[28]  A. Caspi,et al.  How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment , 2009, Psychological Medicine.

[29]  Patrick E. McKnight,et al.  The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. , 2009, Clinical psychology review.

[30]  D. Sheehan,et al.  Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale , 2008, International clinical psychopharmacology.

[31]  Ronald C. Kessler,et al.  The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. , 2008 .

[32]  W. Eaton,et al.  Prevalence and incidence of depressive disorder: the Baltimore ECA follow‐up, 1981–2004 , 2007, Acta psychiatrica Scandinavica.

[33]  T. Vos,et al.  The burden of major depression avoidable by longer-term treatment strategies. , 2004, Archives of general psychiatry.

[34]  T. B. Üstün,et al.  Global burden of depressive disorders in the year 2000 , 2004, British Journal of Psychiatry.

[35]  Gavin Andrews,et al.  Lifetime prevalence estimates of major depression: An indirect estimation method and a quantification of recall bias , 2004, European Journal of Epidemiology.

[36]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[37]  Jan J Barendregt,et al.  A generic model for the assessment of disease epidemiology: the computational basis of DisMod II , 2003, Population health metrics.

[38]  P. Munk-Jørgensen,et al.  Acta Psychiatrica Scandinavica , 1998 .

[39]  D. Sheehan,et al.  The measurement of disability , 1996, International clinical psychopharmacology.

[40]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[41]  G. Simon,et al.  Recall of psychiatric history in cross-sectional surveys: implications for epidemiologic research. , 1995, Epidemiologic reviews.

[42]  Michael P. Todaro,et al.  World Development Report 1990. , 1990 .